Egis in the World

Our products reach 100 countries

Click here to learn more

Pharmaceutical Company

Our activities incorporate all areas in the pharmaceutical value chain

Click here to learn more

Research & Development

One of the fundamental pillars of our strategy is innovation. We devoted EUR 48 million to research and development in the 2022/2023 financial year.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners

Egis in the World

Egis’ products reach 100 countries around the world.

Egis’ products reach 100 countries. Our portfolio consists of 653 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for visitors with qualification in medicine or pharmaceuticals These contents are available with password protection - please contact our representative or require your own account at the Contact menu.

Learn more
Terapeutické oblasti
Terapeutické oblasti
Anti inflammatory
Cardiovascular system
Central nervous system
Women´s health

Safety and quality

If you suspect an adverse reaction related to the use of EGIS, or a suspected quality problem or counterfeit, please contact:

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox